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Synthesis of Four Diastereomers of Sclerophytin F and Structural 
Reassignment of Several Sclerophytin Natural Products 
J. Stephen Clark*, Laëtitia Delion and Louis J. Farrugia[a] 
 
Abstract: The synthesis of the triol that has been proposed to be the 
marine natural product sclerophytin F has been completed along 
with the syntheses of three diastereomers. Comparison of the NMR 
data for all four compounds to the data reported for the natural 
product reveals that sclerophytin F is not the 3S diastereomer of 
sclerophytin A as proposed by Friedrich and Paquette. Re-analysis 
of the NMR data for known sclerophytin natural products and 
synthetic analogues leads to the conclusion that sclerophytins E and 
F are the same compound. This finding has allowed structural 
reassignment of several other cladiellin natural products.  
Introduction 
 The cladiellins (also termed eunicellins) are a large family of 
C-2,C-11 cyclised ether-bridged cembranoids that have been 
isolated from various marine invertebrates.[1] The compounds 
display significant structural diversity with regard to the type and 
position of substituents adorning the C20 skeleton and exhibit a 
range of biological activities. Members of the sclerophytin sub-
class of the cladiellin natural products possess a high degree of 
oxygenation in the medium-ring and have ester or hydroxyl 
groups located at the C-3, C-6 and C-7 positions (Figure 1).[2,3]   
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Figure 1. Originally proposed structures (1 and 2) for sclerophytins A and B, 
and five sclerophytins (3−7) the structures of which have been confirmed by 
synthesis or X-ray analysis. 
 The first members of the sclerophytin sub-class to be isolated 
were sclerophytins A and B (Figure 1).[2] These compounds 
were reported to be doubly ether-bridged compounds with the 
stereochemically ambiguous structures 1 and 2 (Figure 1). 
Sclerophytin A was reported to display potent activity against the 
L1210 leukemia cells at a concentration of 1 ng mL–1.[2] 
 Contemporaneous synthetic studies by the research groups of 
Paquette and Overman showed that the structures (1 and 2) 
assigned to sclerophytins A and B were incorrect.[4] After 
painstaking detective work, Paquette, Overman and their co-
workers deduced that sclerophytin A is the triol 3 and that 
sclerophytin B is the C-6 acetate (4), then synthesised both 
natural products to prove their structures (Figure 1).[4d–g] Several 
other groups have verified the structures of sclerophytins A and 
B by total synthesis,[5] and the structures of the closely related 
natural products sclerophytin F methyl ether (5) (which should 
be re-named sclerophytin A methyl ether) and patagonicol (6) 
have been confirmed by X-ray crystallography (Figure 1).[6,7] 
 In 1989, Alam and co-workers isolated and characterized four 
additional  sclerophytins (C–F) from the soft coral Sclerophytum 
capitalis; the structure of sclerophytin C (7), which bears an 
additional hydroxyl group at C-8, was confirmed by X-ray 
crystallography (Figure 1).[3] The research groups of Ochi and 
Shibata, and of Rao and Faulkner isolated several compounds 
of the same type, including litophynin E, 6-acetoxy litophynin E, 
6-ethoxy sclerophytin E and 6-isovaleroyl sclerophytin E, from 
soft corals and also re-isolated some of the sclerophytins that 
had been discovered by Alam and co-workers.[8–10] 
 In 2002, Friedrich and Paquette raised doubts about the 
stereochemical assignments given to sclerophytins E and F by 
Alam and co-workers and also the assignments given to 
litophynin E, 6-acetoxy litophynin E, 6-ethoxy sclerophytin E and 
6-isovaleroyl sclerophytin E.[11] Friedrich and Paquette re-
analysed the NMR data for all members of the sclerophytin 
family and concluded that sclerophytin E, sclerophytin F, 
litophynin E, 6-acetoxy litophynin E, 6-ethoxy sclerophytin E and 
6-isovaleroyl sclerophytin E are compounds 8–13 (Figure 2) 
possessing inverted configuration at C-3 compared to 
sclerophytins A and B (Figure 1). Friedrich and Paquette based 
their structural reassignments for the whole group mainly on the 
basis of the large 13C NMR chemical shift differences (+11.8 and 
–7.1 ppm) between the peaks arising from C-3 and C-18 in the 
supposed triol sclerophytin F when compared to the 
corresponding peaks in 13C NMR spectrum of sclerophytin A.[11] 
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Figure 2. Structures of various sclerophytin diterpenes proposed by Paquette 
and Friedrich (ref. 11). 
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Results and Discussion 
 At the outset, our objective was to confirm or disprove the 
reassigned structure of sclerophytin F by synthesising the triol 
9.[12] Retrosynthetic analysis of this compound was undertaken 
as shown in Scheme 1. Replacement of the hydroxyl groups at 
C-6 and C-7 with an alkene and masking of the C-3 hydroxyl 
group leads to the diene i. Removal of the methylene group (C-
20) and replacement of a side-chain methyl substituent with a 
carbonyl group reveals the diketone ii. Replacement of the C-11 
carbonyl group with an enol ether spanning C-10–C-11 leads to 
the ketone iii and Diels-Alder bond disconnection at C-12–C-13 
and C-14–C-1 affords the diene iv. Disconnection through the 
alkoxy diene of iv leads to the ketone v, a key intermediate in 
our synthesis. The bridged-bicyclic ether structure of v can be 
simplified to reveal the diazo ketone vi and removal of the 
diazomethyl group and the silyl ether leads to the 
tetrahydropyranol vii. Disconnection between the positions 2 
and 3 on the ring gives the vinylogous carbonate viii, which is 
analogous to an early intermediate in our previous total 
syntheses of related cladiellin natural products.[5c,13]    
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Scheme 1. Retrosynthetic analysis of the proposed structure of sclerophytin F. 
 In the synthetic route implied by the retrosynthetic analysis 
(Scheme 1), installation of the C-3 methyl substituent is to be 
performed at an early stage. This contrasts with the strategy 
employed during our recent total syntheses of sclerophytins A 
and B – targets possessing R configuration at C-3 – in which the 
C-3 methyl group was introduced at a very late stage.[5c] In the 
proposed synthesis of sclerophytin F, introduction of C-3 methyl 
substituent would be performed prior to formation of the bridged-
bicyclic ether v by rearrangement of the free or metal-bound 
oxonium ylide that is a presumed intermediate this key 
transformation. In adopting this approach, we were aware that 
the substrate might behave differently in the key reaction, 
compared to related substrates, resulting in poor yields and low 
levels of diastereocontrol. 
 The synthesis of the α-diazo ketone 19, the intermediate that 
would serve as the substrate in the key ring-forming reaction, 
commenced from the alcohol 14 (91–96% ee) (Scheme 2). This 
compound had been used an intermediate during our syntheses 
of related cladiellin natural products including sclerophytins A 
and B.[5c,13] Oxidation of the alcohol 14 with pyridinium 
chlorochromate (PCC) afforded the aldehyde 15 and 
subsequent sequential nucleophilic addition of 
trimethylaluminium and Swern oxidation afforded the methyl 
ketone 16. Treatment of the ketone 16 with samarium(II) iodide 
resulted in reductive cyclisation of the ketone on to the 
vinylogous carbonate to provide the tetrahydropyranol 17 in 
excellent yield (>12:1 selectivity).[14] Protection of the alcohol as 
a TBS ether afforded the ester 18 and this was converted into 
the corresponding carboxylic acid under basic conditions. The α-
diazo ketone 19 was obtained by sequential reaction of the 
carboxylic acid with isobutylchloroformate and treatment of the 
resulting mixed anhydride with diazomethane (Scheme 2). 
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Scheme 2. Synthesis of diazo ketone 19, the substrate for the key cyclisation 
and rearrangement reaction. 
 The ketone 16 required for the reductive cyclisation reaction 
could be prepared from a commercially available lactone instead 
(Scheme 3). Lactone 20, the antipode (S enantiomer) of the 
requisite starting material, was used to explore the viability of the 
route because it is more readily available than the R enantiomer. 
Conversion of the carboxylic acid into the acid chloride and 
treatment with methylmagnesium bromide delivered the methyl 
ketone 21.[15] Subsequent Wittig methylenation afforded the 
known alkene 22[15a] and this compound was converted into (S)-
16 by ring opening with methylithium and treatment of the 
resulting alcohol with ethyl propiolate and N-methylmorpholine. 
Although this route to the ketone 16 was shorter than the original 
one, the product was found to have low ee, presumably due to 
 
 
 
 
 
partial racemisation during formation or methylenation of the 
ketone 21. Further optimization of the route was not performed 
because the original route was deemed to be satisfactory for the 
production of large quantities of the ketone 16 with high ee.     
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Scheme 3. Synthesis of the ketone (S)-16 starting from the commercially 
available lactone 20. 
 In previous work, we had shown that copper- or rhodium-
catalysed reactions of the α-diazo ketone 23 (lacking a C-3 
methyl group) deliver the isomeric bridged-bicyclic ethers Z- and 
E-24 in excellent yield and that the product ratio is dependent on 
the metal complex employed as the catalyst and the reaction 
conditions (Scheme 4).[5c,13b,16] We had also shown that the 
reaction of the α-diazo ketone 23 can be tuned to give either Z- 
or E-24 as the major product (>6:1 selectivity) by selecting the 
appropriate catalyst and solvent. However, it was unclear what 
influence the methyl substituent at the 3-position of the 
tetrahydropyran would have on the reaction yield or the product 
ratio. It was conceivable that the substrate 19 would undergo the 
key reaction in poor yield and/or deliver the isomeric products 
with low selectivity.  
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Scheme 4. Metal-catalysed reaction of the α-diazo ketone 23 and 
rearrangement of the resulting ylide or metal-bound ylide to give the bridged-
bicyclic ethers Z-24 and E-24. 
 The metal-catalysed reaction of the α-diazo ketone 19 to give 
the isomeric bridged-bicyclic ethers Z-25 and E-25 was explored. 
In preliminary experiments, a copper or rhodium complex was 
employed as the catalyst and reactions were performed in 
dichloromethane at reflux (Scheme 5 and Table 1). In contrast to 
what had been observed for reactions of the α-diazo ketone 
23,[5c,13b] the Z-isomer (Z-25) was the major or sole product in 
every case. The highest yield (98%) was obtained when 
copper(II) hexafluoroacetylacetonate was employed as the 
catalyst, but the diastereoselectivity (1.8:1, Z:E) was low (entry 2, 
Table 1). The use of rhodium(II) acetate as the catalyst afforded 
a higher degree of selectivity (7.5:1, Z:E) but the yield was less 
impressive (entry 3, Table 1). The Z-isomer was obtained 
exclusively when rhodium(II) triphenyl acetate was employed as 
the catalyst, but in this case the yield was very low (entry 8, 
Table 1).  
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Scheme 5. Metal-catalysed reaction of the α-diazo ketone 19 and ring-
expanding, rearrangement of the resulting ylide or metal-bound ylide to give 
the bridged-bicyclic ethers Z-25 and E-25. 
Table 1. Preliminary screen of catalysts for the reaction of diazo 
ketone 19 in dichloromethane at reflux (Scheme 5). 
Entry      Catalyst(%)[a]   Time (min)    Yield (%)[b]          Z:E ratio[c,d]              
1 Cu(tfacac)2 30 70  2.3:1  
2 Cu(hfacac)2 60 98  1.8:1  
3 Rh2(OAc)4 30 42  7.5:1  
4 Rh2(pfm)4 15 61  5.0:1  
5 Rh2(tfa)4 15 69  3.1:1  
6 Rh2(pfb)4 30 69  2.1:1  
7 Rh2(tfacam)4 90 72  2.0:1  
8 Rh2(tpa)4 30 14  Z only  
[a] tfacac = CF3COCHCOCH3; hfacac = CF3COCHCOCF3; pfm 
= HNCOC3F7; tfa = O2CCF3; pfb = O2CC3F7; tfacam = 
HNCOCF3; tpa = O2CCPh3. [b] Combined isolated yield of E-25 
and Z-25. [c] Isomer ratio determined by 1H NMR analysis of the 
crude reaction mixture.  
 
 It was not possible to identify a catalyst that would deliver both 
a high yield and good stereoselectivity. Fortunately, the less 
thermodynamically favourable isomer, E-25, could be converted 
into Z-25 by treatment with ethanethiol under radical conditions 
(Scheme 5).[17] This discovery meant that the mixture of isomeric 
products obtained from the high-yielding reaction catalysed by 
copper(II) hexafluoroacetylacetonate could be converted into a 
single compound in high yield. The ketone Z-25 was crystalline 
(in racemic form) and so the structure of this compound was 
verified by single crystal X-ray crystallography.[18]  
 On the basis of the results obtained during the initial screen of 
various copper and rhodium complexes (Table 1), copper(II) 
hexafluoroacetylacetonate and rhodium(II) perfluorobutyramide 
were selected as catalysts in order to explore the influence of 
solvent and temperature on reaction yield and stereoselectivity 
(Table 2 and Scheme 5). These results revealed that copper(II) 
hexafluoroacetylacetonate catalysed reactions are generally 
 
 
 
 
 
lower yielding when performed in solvents (entries 1–5, Table 2) 
other than dichloromethane (entry 2, Table 1). However, higher 
stereoselectivity (>20:1, Z:E) is obtained when the reaction is 
performed in THF (entry 1, Table 2). We also discovered that 
rhodium(II) perfluorobutyramide catalysed reactions are low 
yielding when performed in solvents (entries 6–8, Table 2) other 
than dichloromethane (entry 4, Table 1), but the reactions are 
more stereoselective. However, when the reaction is performed 
in 1,2-dichloroethane at reflux (entry 9, Table 2), a higher yield 
(68%) is obtained and the reaction is relatively stereoselective 
(6.3:1, Z:E).  
 
Table 2. Screen of solvents (at reflux) for the reaction of diazo ketone 19 
(Scheme 5). 
Entry      Catalyst[a]          Solvent    Time (min)   Yield (%)[b]       Z:E ratio[c]              
1 Cu(hfacac)2 THF 30 39 >20:1  
2 Cu(hfacac)2 PhMe 30 49 3.0:1  
3 Cu(hfacac)2 DCE 30 77 2.9:1  
4 Cu(hfacac)2 MeCN 150 22 1.3:1  
5 Cu(hfacac)2 Et2O 240 17 Z only  
6 Rh2(pfm)4 THF 30 31 >20:1  
7 Rh2(pfm)4 MeCN 20 32 >20:1  
8 Rh2(pfm)4 PhMe 30 29 13:1  
9 Rh2(pfm)4 DCE 30 68 6.3:1  
[a] hfacac = CF3COCHCOCF3; pfm = HNCOC3F7. [b] Combined isolated 
yield of E-25 and Z-25. [c] Isomer ratio determined by 1H NMR analysis 
of the crude reaction mixture. 
 
 Stereoselective construction of the bridged-bicyclic ether Z-25 
meant that elaboration of this compound to give the tricyclic 
cladiellin core could be investigated (Scheme 6). The synthetic 
strategy employed was analogous to the one used by us to 
synthesise related members of the cladiellin family of natural 
products.[5c,13] Conversion of the ketone Z-25 into the enol triflate 
followed by Heck coupling with ethyl vinyl ether afforded the 
diene 26. Intermolecular thermal Diels-Alder cycloaddition of the 
diene 26 with methyl vinyl ketone afforded tricyclic ketone 27 in 
excellent yield (69% over three steps) as a mixture of exo and 
endo isomers (1:1 diastereomeric mixture at C-14). Attempted 
epimerisation of the diastereomeric mixture of ketones 27 using 
potassium carbonate, sodium hydroxide, sodium methoxide or 
potassium t-butoxide in methanol or ethanol, or by employing 
DBU in an aprotic solvent, failed to alter the ratio of 
diastereomers significantly. Fortunately, treatment of the mixture 
of isomers with HCl in methanol resulted in hydrolysis of the enol 
ether and cleavage of TBS ether with concomitant epimerisation 
at the C-14 stereocentre to give the crystalline diketone 28 as a 
single isomer in good yield. The structure of this compound 
(racemic form) was confirmed by single crystal X-ray 
crystallography.[18] 
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Scheme 6. Conversion of the bicyclic ketone Z-25 into the tricyclic diketone 28 
using an intermolecular Diels-Alder cycloaddition reaction. 
 Selective functionalisation of the diketone 28 was necessary in 
order to elaborate this compound to give the proposed structure 
of sclerophytin F. Surprisingly, methylenation of the the diketone 
28 using a conventional Wittig reaction afforded a separable 
mixture of the diene 29 (69% yield) and the triene 30 (14% yield), 
without formation of the product arising from mono-
methylenation of the methyl ketone (Scheme 7).  
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Scheme 7. Selective Wittig methylenation of the diketone 28. 
 Protection of the tertiary alcohol in the diene 29 as a TES 
ether followed by addition of methylmagnesium chloride 
completed the carbon framework and delivered the alcohol 31 in 
good yield (Scheme 8). Side-chain deoxygenation was then 
performed using the procedure developed by Barrett and co-
workers,[19] which has recently employed by Kim and co-workers 
and by us to prepare related cladiellin natural products.[5c,13b,20] 
Thus, acetylation of the alcohol followed by treatment of the 
ester with potassium, 18-crown-6 and t-butylamine in THF at 
room temperature afforded the silyl ether 32 and the alcohol 33 
in a combined yield of 56%. Subjection of the silyl ether 32 to 
acid-catalysed deprotection gave the crystalline alcohol 33 in 
high yield and its structure was confirmed by X-ray 
crystallography (Scheme 8).[18]   
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Scheme 8. Introduction of the isopropyl side-chain by conversion of the methyl 
ketone 29 into the alcohol 33. 
 The trisubstituted alkene of the diene 33 was epoxidised 
stereoselectively using m-chloroperbenzoic acid (Scheme 9). 
Attempted opening of the epoxide 34 to give a triol by exposure 
to scandium(III) triflate,[5a] afforded the C-6 allylic alcohol 35 
instead. Treatment of the epoxide 34 with aqueous acid 
produced the allylic alcohol 35 in higher yield (77%) along with 
the triol 36 in 15% yield. The structure of the crystalline allylic 
alcohol 35 was confirmed by X-ray crystallography.[18] 
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Scheme 9. Stereoselective and chemoselective epoxidation of the diene 33 
and acid-catalysed ring opening of the resulting epoxide (34). 
 In order to prepare the compound that had been proposed to 
be sclerophytin F (i.e. the triol 9) from the allylic alcohol 35, it 
was necessary to invert the configuration at the C-6 stereocentre 
(Scheme 10). Inversion of configuration was performed by 
sequential oxidation of the allylic alcohol 35 with the Dess-Martin 
periodinane and reduction of the intermediate enone under 
Luche conditions. This sequence delivered the required allylic 
alcohol 37 (57% yield) along with the original C-6 diastereomer 
35 (38% yield). The synthesis of the triol 9 was completed by 
Sharpless asymmetric epoxidation to deliver the crystalline C-7 
spiro-epoxide 38, the structure of which was confirmed by X-ray 
crystallography,[18]  and subsequent reductive opening at the less 
hindered position using diisobutylaluminium hydride (DIBAL-H).  
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Scheme 10. Synthesis of the triol 9 corresponding to the structure of 
sclerophytin F as proposed by Friedrich and Paquette.  
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Scheme 11. Syntheses of the triols 36, 41 and 42 corresponding to the C-6 
and C-7 diastereomers of proposed structure of sclerophytin F. 
 
 
 
 
 
 Comparison of the 1H and 13C NMR data obtained for the triol 
9 to those reported for natural sclerophytin F showed that these 
compounds are not the same. It was conceivable that we had 
prepared a diastereomer of sclerophytin F and so the syntheses 
of the diastereomeric triols possessing varying configurations at 
C-6 and C-7 were undertaken. All three compounds were 
prepared from the diol 35, a compound that served as an 
advanced intermediate for the synthesis of the triol 9.  
 Vanadium-catalysed epoxidation of the allylic alcohol 35 with 
t-butyl hydroperoxide afforded a separable mixture of the 
diastereomeric (C-7) crystalline spiro-epoxides 39 and 40 (1:1.6 
ratio) in 73% yield (Scheme 11), the structures of which were 
confirmed by X-ray crystallography.18 Opening of the epoxide 39 
at the less hindered position using DIBAL-H delivered the target 
triol 41 in modest yield. Treatment of the diastereomeric epoxide 
40 under the same conditions produced the second target triol 
36. The triol 36 had been obtained as a minor product upon 
treatment of the epoxide 34 with aqueous acid (Scheme 9). 
 The final compound required for comparison purposes, triol 42, 
was obtained by oxidation of the triol 36 using Dess-Martin 
periodinane and reduction of the resulting keto diol with DIBAL-
H (Scheme 11). Although the triol 42 was obtained in low yield 
over the two steps along with triol 36, a sufficient quantity of this 
compound was prepared to enable full characterization. 
 
Table 3. Comparison of 13C NMR chemical shifts (in CDCl3) of natural 
sclerophytin F with those of a synthetic sample of 9 and the three other C-
6 and C-7 diastereomers 36, 41 and 43. 
Position        F[a]                 9[b,c]                      36[c,d]                    41[c,d]              42[c,d] 
1 45.4 42.3 44.4 43.3 44.1  
2 91.9 87.0 91.8 90.4 90.8  
3 86.6 73.9/75.1 74.4/76.3 73.6/74.7 74.8/75.5  
4 35.9 33.2 34.2 33.2 35.1  
5 30.5 29.8 30.8 28.2 29.2  
6 80.1 75.4 79.8 76.8 76.3  
7 77.0 73.9/75.1 74.4/76.3 73.6/74.7 74.8/75.5  
8 45.8 45.2 44.2 46.3 45.6  
9 78.2 75.8 77.4 76.1 77.5  
10 52.9 47.8 48.5 48.4 50.8  
11 147.6 146.1 146.2 146.0 146.7  
12 31.4 30.3 28.7 30.4 30.9  
13 24.7 24.8 25.0 24.8 24.9  
14 43.9 40.5 41.8 41.2 42.1  
15 29.1 29.4 29.0 29.5 29.4  
16 21.9 22.2 22.0 22.1 22.0  
17 15.7 20.7 18.4 19.8 18.5  
18 23.2 28.5 27.9 29.8 27.5  
19 22.3 22.7 26.5 28.3 26.1  
20 109.3 107.9 109.7 108.8 108.9  
[a] Data given in ref. 3. [b] Data recorded at 151 MHz. [c] It is not possible 
to differentiate between the C-3 and C-7 signals with certainty. [d] Data 
recorded at 126 MHz. 
 The 1H and 13C NMR data for the triols 9, 36, 41 and 42 were 
compared to the data reported for sclerophytin F (Table 3).[3] 
Significant differences between the 13C NMR data for all four 
triols and those of sclerophytin F were immediately obvious, 
particularly between the 13C NMR signals for C-3, C-6 and C-7. 
The 13C chemical shift for C-3 signal appears at 86.6 ppm for 
sclerophytin F but the chemical shifts for the corresponding 
carbon in the triols 9, 36, 41 and 42 lie below 76.3 ppm. A 
similar but less pronounced discrepancy is evident with the 
regard to the 13C NMR chemical shifts of signals for C-6 and C-7, 
which appear at lower values in the case of triols 9, 36, 41 and 
42 than in sclerophytin F. The chemical shifts of signals arising 
from carbons at the C-1, C-4, C-10, C-14, C-17 and C-18 
positions in the 13C NMR spectrum of sclerophytin F also differ 
significantly from those of the corresponding peaks in the 13C 
NMR spectra of triols 9, 36, 41 and 42. 
 The four diastereomeric triols (9, 36, 41 and 42) possessing S 
configuration at C-3 had been prepared and none of these 
compounds was sclerophytin F. The fact that these triols did not 
correspond to natural product meant that further comparison of 
the NMR data for related compounds was required in order to 
deduce the structure of sclerophytin F. 
 In a further attempt to identify sclerophytin F, the 1H and 13C 
NMR data for the four triols possessing R configuration at C-3 
were considered. One of the compounds in this group is 
sclerophytin A and it is clear that this natural product is not the 
same as sclerophytin F. We prepared the diastereomeric triol 44 
(7-epi-sclerophytin A) by diastereoselective dihydroxylation of 
the diene 43,[21] a compound that had served as a key 
intermediate during our synthesis of vigulariol (Scheme 
12).[5e,13a] 
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Scheme 12. Stereoselective dihydroxylation of the diene 43 to give the triol 44. 
 Sclerophytin A, 7-epi-sclerophytin A (44) plus two other 
diastereomeric compounds with varying configurations at C-6 
and C-7 had been prepared by Paquette and co-workers.[4e,f] 
These workers reported that reduction of the hydroxyketone 45 
delivers the triols 44 and 46 and that the choice of reducing 
agent dictates the stereochemical outcome of the reaction 
(Scheme 13). Comparison of the 1H and 13C NMR data for our 
triol 44 with those reported by Paquette and co-workers revealed 
that our triol is identical to the compound produced by reduction 
of the hydroxyketone 45 using DIBAL-H but identifed as the triol 
46 by Paquette and co-workers.[4e,f] Given that the compound 
prepared by us is known to be the syn 1,2-diol resulting from 
dihydroxylation of a Z-alkene, we are confident that the 
structures assigned to the triols 44 and 46 by Paquette and co-
workers are incorrect and that the compound produced by 
 
 
 
 
 
reduction of the hydroxyketone 45 with DIBAL-H is in fact the 
triol 44 rather than the triol 46. 
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Scheme 13. Reduction of the hydroxy ketone 45 to give the diastereomeric 
triols 44 and 46 with assignments as reported by Paquette and co-workers. 
 The 1H and 13C NMR data for sclerophytin F were compared to 
those of sclerophytin A, the triol 44 and the two other 
diastereomeric triols prepared by Paquette and co-workers that 
possess R configuration at C-3.[4e,f] The NMR data for the four 
triols did not match those reported for sclerophytin F. 
 At this stage, six of the eight diastereomeric triols with varying 
configurations at C-3, C-6 and C-7 had been prepared by us and 
the remaining two had been reported by Paquette and co-
workers. None of these diastereomeric triols was sclerophytin F 
and so in order to identify the natural product it was necessary to 
re-analyse and compare the original NMR data to those reported 
for closely related cladiellin natural products.  
 Inspection of the data reported by Alam and co-workers for 
sclerophytins E and F reveals some anomalies and raises 
doubts about the assignments for both compounds.[3] The first 
problem is that the mass spectrum given for sclerophytin F is not 
consistent with the assigned molecular formula (C20H34O4). The 
molecular ion is given as 363 whereas the mass of the 
molecular ion for sclerophytin F should be 338, if the molecular 
formula is correct. The heaviest ion in the mass spectrum for 
sclerophytin E appears at 338 which could mean that ionisation 
has resulted in loss of the acetate group or that this compound is 
actually a triol with molecular formula C20H34O4. Finally, the 
chemical shifts for the carbon framework signals in the 13C NMR 
spectra for sclerophytins E and F are almost identical and the 
chemical shifts of the signals corresponding to C-3 differ by only 
0.3 ppm, which is inconsistent with sclerophytin E being the C-3 
acetate of sclerophytin F. A chemical shift difference of several 
ppm would be expected on the basis of the observed differences 
in the 13C NMR spectra of sclerophytins A (3) and B (4), for 
example (Figure 1). The 1H NMR spectra for sclerophytins E and 
F are also very similar and the chemical shifts and coupling 
constants are identical for many signals. It should be 
appreciated that comparison of data for sclerophytins E and F is 
complicated by the fact that the original publication describing 
their isolation contains significant typographical errors.[3] 
 Inspection of the 13C NMR data for the closely related natural 
products 3–6 (Figure 1),[2,6,7] the structures of which have been 
verified by total synthesis or X-ray crystallography, and 
comparison with the 13C NMR data for sclerophytin F reveals 
some interesting trends (Table 4). It is clear that the 13C NMR 
data for sclerophytin F are very similar (≤0.3 ppm chemical shift 
difference) to those of sclerophytin A, apart from the chemical 
shifts of the signals arising from C-2–C-5 and C-18. This 
observation suggests the compounds are very similar but the C-
3 hydroxyl group of sclerophytin F is functionalised in some way. 
Another significant observation is that the 13C NMR data for 
sclerophytins E and F are very similar to those of sclerophytin C 
(7), especially with regard to the signals arising from C-2–C-5 
and C-18. The only major differences are between the signals 
resulting from the C-6–C-9, as a consequence of the C-8 
hydroxyl group in sclerophytin C (Table 4). 
 
Table 4. Comparison of 13C NMR chemical shifts (in CDCl3) for 
sclerophytins 3–7, the structures of which have been secured by total 
synthesis or X-ray analysis. 
Position         3[a]             4[a]            5[b,c]           6[c–e]           F[f]             7[f] 
1 45.2 45.5 44.6 45.3 45.4 45.0  
2 90.5 90.5 90.5 91.1 91.9 91.4  
3 74.8 74.8 74.9 74.4 86.6 86.2  
4 39.9 39.8 41.0 40.9 35.9 34.5  
5 29.4 28.1 30.0 27.2 30.5 29.5  
6 79.9 85.0 90.5 88.4 80.1 77.0  
7 77.0 75.9 76.1 76.1 77.0 79.6  
8 45.4 45.5 45.1 45.1 45.8 79.5  
9 78.2 78.0 78.1 78.6 78.2 81.1  
10 52.6 53.2 53.0 53.8 52.9 52.5  
11 147.9 147.9 147.9 148.4 147.6 148.6  
12 31.6 31.9 31.6 31.9 31.4 31.6  
13 24.9 24.8 25.9 25.2 24.7 24.8  
14 43.7 43.6 43.7 44.0 43.9 43.7  
15 29.1 29.0 29.0 29.3 29.1 29.0  
16 16.0 16.1 15.9 15.7 15.7 16.2  
17 22.0 21.9 22.0 22.1 21.9 21.9  
18 30.3 30.2 29.4 29.9 23.2 23.0  
19 23.1 23.7 23.9 24.8 22.3 17.7  
20 109.1 109.2 109.1 109.2 109.3 109.9  
  171.8 57.0 64.8  169.5  
  21.5  15.3  22.7  
[a] Data reported in ref. 2. [b] Data reported in ref. 6, but peaks for C-3, C-
7, C-13, C-18 and C-19 appear to have been assigned incorrectly and 
have been corrected. [c] Structure confirmed by X-ray analysis. [d] Data 
reported in ref. 7. [e] The 13C NMR spectrum was recorded in C6D6. [f] Data 
reported in ref. 3. 
  
 Comparison of the 13C NMR data for sclerophytins E and F 
with those of the other sclerophytin natural products reassigned 
by Friedrich and Paquette as having S configuration at C-3, 
shows that the compounds are very similar (Table 5). Significant 
differences in chemical shift are restricted to signals 
corresponding to C-5–C-7, suggesting that the C-6 substituent 
accounts for the structural differences between the compounds.
 
 
 
 
 
 
Table 5. Comparison of 13C chemical shifts (in CDCl3) for sclerophytins 
reassigned by Friedrich and Paquette in 2002 (ref. 11). 
Position     F[a]               E[a,b]          6-ethoxy         6-isovaleroyl    litophynin E[c]              
                                                 sclerophytin E[c]  sclerophytin E[c] 
1 45.4 45.2   (45.5)  45.3 45.8 45.4  
2 91.9 92.0   (91.9) 92.1 92.1 92.0  
3 86.6 86.3   (86.7) 86.4 86.7 86.4  
4 35.9 36.1   (36.0) 36.6 35.7 36.1  
5 30.5 30.4   (30.6) 27.5 29.3 30.4  
6 80.1 80.1   (79.8) 88.3 84.5 80.1  
7 77.0 77.0   (76.8) 75.9 75.5 76.8  
8 45.8 45.7   (46.0) 44.9 45.8 45.8  
9 78.2 78.2   (78.4) 78.5 78.1 78.2  
10 52.9 52.9   (53.6) 53.9 53.8 53.6  
11 147.6 147.6 (147.7) 147.8 147.6 147.6  
12 31.4 31.4   (31.5) 31.5 31.5 31.4  
13 24.7 24.8   (24.7) 24.6 24.6 24.6  
14 43.9 43.9   (44.0) 44.0 43.8 43.8  
15 29.1 29.0   (29.1) 29.0 29.0 29.0  
16 15.7 16.1   (15.8) 15.5 15.4 15.6  
17 21.9 21.9   (22.0) 21.9 21.9 21.9  
18 23.2 23.2   (23.2) 23.1 22.9 23.2  
19 22.3 22.6   (22.3) 23.8 23.8 22.6  
20 109.3 109.3 (109.4)  109.5 109.5 109.3  
  170.1 (169.2) 169.9  169.6  172.5  
  22.7   (22.5) 22.3  22.4  37.3  
   64.6 173.9 18.3  
   15.5 43.8 13.7  
    25.8   
    22.9   
[a] Data reported in ref. 3. [b] The C-19 peak at 22.6 ppm was given as 24.6 
ppm in ref. 3, but the data reported in ref. 9 (given in brackets) shows this 
must be a typographical error. [c] Data reported in ref. 9. 
 The 1H and 13C NMR data reported for sclerophytins E and F 
are almost identical and sclerophytin F is clearly not a 
diastereomer of sclerophytin A. Complete analysis of the 13C 
NMR data for sclerophytin A (3) and the seven other 
diastereomeric triols having R or S configuration at C-3, C-6 and 
C-7, and comparison of these data to those of the natural 
products 4–7, 6-ethoxy sclerophytin E, 6-valeroyl sclerophytin E 
and litophynin E leads us to the conclusion that sclerophytin F is 
simply re-isolated sclerophytin E, a finding that is consistent with 
the original mass spectrometry data.[3] Based on all the available 
data, and in particular comparison of the 13C NMR data for 
sclerophytin E with those of sclerophytins A and C, it is clear that 
sclerophytin E is the C-3 acetate of sclerophytin A. This is the 
structure that was assigned to sclerophytin E by Alam and co-
workers[3] and by Rao, Faulkner and co-workers,[9] prior to the 
structural reassignment of several sclerophytins by Friedrich and 
Paquette in 2002.[11] The fact that sclerophytins E and F are the 
same compound is particularly evident when appreciates that 
the 13C NMR data for the triols 9, 36, 41 and 42 show a much 
lower degree of homology than do the 13C NMR data for 
sclerophytins E and F, even though the four triols have simple 
diastereomeric relationships (Table 3).  
 The failure of Alam and co-workers to report the signals 
corresponding the acetate group in the 13C NMR spectrum of 
sclerophytin F is puzzling, but could be explained by overlap of 
the 13C NMR signal of the acetate methyl group (δ 22.6 ppm) 
with that of C-19 (δ 22.7 ppm) and the use a very weak sample 
leading to a low intensity signal for the carbonyl group. In the 1H 
NMR spectrum of sclerophytin F, the signal arising from the 
acetate methyl group (reported to appear at δ 2.02 ppm in the 1H 
NMR spectrum of sclerophytin E) could have been attributed to, 
or obscured by, the presence of water in the NMR sample.[22] 
 The discovery that sclerophytins E and F are the same 
compound and that the original structural assignment for 
sclerophytin E is correct means that we are able to correct the 
structures of related sclerophytin-type natural products that were 
reassigned incorrectly by Friedrich and Paquette.[11] Thus, 
sclerophytin E/F (47) is the C-3 acetate of sclerophytin A and 6-
ethoxy sclerophytin E, 6-isovaleroyl sclerophytin E are 
compounds 48 and 49 i.e. sclerophytin E has the structure 
proposed originally by Alam and co-workers and the others have 
the structures assigned by Rao, Faulkner and co-workers 
(Figure 3).[9] The very close correlation between the 13C NMR 
data for sclerophytin E and litophynin E suggests that the only 
difference between these compounds is the type of ester group 
at C-3 and that litophynin E is ester 50, which is the C-7 
diastereomer of the compound proposed by Ochi and co-
workers following their isolation of the natural product.[8a] It then 
follows that 6-acetoxy litophynin E is the diester 51 (Figure 3).  
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Figure 3. Reassigned structures of the sclerophytins. 
Conclusions 
The compound purported to be sclerophytin F and three 
diastereomeric (at C-6 and C-7) triols have been synthesised. 
The NMR data for each of these compounds do not match the 
data reported for sclerophytin F. Analysis of the NMR data for 
the four known triols that are diastereomers with respect to their 
configuration at C-3, shows that none of these compounds is 
sclerophytin F either. Careful re-analysis of the 13C NMR data for 
the natural products 3–7 plus the NMR data for sclerophytin E, 
sclerophytin F, 6-ethoxy sclerophytin E, 6-isovaleroyl 
sclerophytin E and litophynin E leads us to the conclusion that 
sclerophytins E and F are the same compound. The structures 
proposed by Friedrich and Paquette for sclerophytin E, 
sclerophytin F and related natural products are incorrect and 
 
 
 
 
 
these compounds are those shown in Figure 3. All of the 
sclerophytins possess the sclerophytin A skeleton but are 
esterified at the C-3 hydroxyl group and/or functionalized at the 
C-6 hydroxyl site i.e. none of the natural sclerophytins 
possesses inverted configuration at C-3. The structures of 
compounds 47–51 are those proposed previously by Rao, 
Faulkner and co-workers.[9] 
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